Jump to navigation
The latest clinical and political news for Australian Cardiologists
Results are out from the largest trials to date.
Fortunately, people with panic attacks rarely present to hospital.
There was a noteable surge in use soon after they became available on the PBS from late 2013.
The capsules contain quarter doses of irbesartan, amlodipine, hydrochlorothiazide and atenolol.
Product review: It's tough to beat the Omron HEM7270 in terms of value for money (★★★★).
They're still in the food supply, despite moves in the 1990s to limit them.
"This is good news for patients," the lead researcher says.
Researchers have developed the first cardiovascular mortality risk score derived entirely from Australian data.
Patients with pulmonary arterial hypertension may have been placed at significant risk, tribunal told.
Over half of patients are left without recommended therapy
It can help identify those in need of intensive hypertension treatment
Harvard researchers are the latest to weigh in
A new study sheds some light on which is best in osteoporosis.
Inside Story: Emily Dunn explores a cardiac dilemma.
As long as it's timed to coincide with a vaccination appointment.
But questions remain about the quality of the evidence.
There’s a threshold below which risk of heart disease increases
The lead investigator of the REVISIT-US study talks to Cardiology Update about outcomes beyond clinical trials
Brazilian study overturns conventional wisdom
The MedicineWise initiative led to a sharp rise in aspirin prescribing
Australian Doctor Group is Australia’s premier business to business publisher, delivering the country’s most recognised industry magazines and websites.
Ensure you never miss a big story by signing up for our daily e-newsletter.